Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Ullrich

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Biotechniques|December 16, 2004
TaqMan-based quantification of invasive cells in the chick embryo metastasis assayEdward Htun van der Horst, Jörg H Leupold, Rainer Schubbert, et al.
Experimental Brain Research|September 4, 2009
Protein tyrosine phosphatases expression during development of mouse superior colliculusJacqueline Reinhard, Andrea Horvat-Bröcker, Sebastian Illes, et al.
DNA and Cell Biology|April 8, 2004
The ability of protein tyrosine phosphatase SHP-1 to suppress NFkappaB can be inhibited by dominant negative mutant of SIRPalphaNickolay Neznanov, Lubov Neznanova, Roman V Kondratov, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinomaMarkus Reschke, Ingvar Ferby, Ewa Stepniak, et al.
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormoneMasayuki Shiota, Tatsuya Tanihiro, Yoshimi Nakagawa, et al.
Oncotarget|May 10, 2019
Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approachZhiguang Xiao, Bianca Sperl, Silvia Gärtner, et al.
Oncotarget|August 26, 2021
Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approachZhiguang Xiao, Bianca Sperl, Silvia Gärtner, et al.
Cancer Detection and Prevention|April 3, 2003
The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimenMiguel Tejeda, Dezsõ Gaál, Orsolya Csuka, et al.
Biological Chemistry|September 17, 2005
GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathwaysStefan Hart, Oliver M Fischer, Norbert Prenzel, et al.
Cellular Signalling|January 18, 2003
The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2Parham Minoo, Naila Chughtai, Manuela Campiglio, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Biotechniques|December 16, 2004
TaqMan-based quantification of invasive cells in the chick embryo metastasis assayEdward Htun van der Horst, Jörg H Leupold, Rainer Schubbert, et al.
Experimental Brain Research|September 4, 2009
Protein tyrosine phosphatases expression during development of mouse superior colliculusJacqueline Reinhard, Andrea Horvat-Bröcker, Sebastian Illes, et al.
DNA and Cell Biology|April 8, 2004
The ability of protein tyrosine phosphatase SHP-1 to suppress NFkappaB can be inhibited by dominant negative mutant of SIRPalphaNickolay Neznanov, Lubov Neznanova, Roman V Kondratov, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinomaMarkus Reschke, Ingvar Ferby, Ewa Stepniak, et al.
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormoneMasayuki Shiota, Tatsuya Tanihiro, Yoshimi Nakagawa, et al.
Oncotarget|May 10, 2019
Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approachZhiguang Xiao, Bianca Sperl, Silvia Gärtner, et al.
Oncotarget|August 26, 2021
Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approachZhiguang Xiao, Bianca Sperl, Silvia Gärtner, et al.
Cancer Detection and Prevention|April 3, 2003
The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimenMiguel Tejeda, Dezsõ Gaál, Orsolya Csuka, et al.
Biological Chemistry|September 17, 2005
GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathwaysStefan Hart, Oliver M Fischer, Norbert Prenzel, et al.
Cellular Signalling|January 18, 2003
The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2Parham Minoo, Naila Chughtai, Manuela Campiglio, et al.
Pageof 13